Delivery Order SPE2DB22D2206-SPE2DB24FJA05
Award Date
7/1/24
Potential Completion Date
7/2/24
Potential Value
$2.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of FLUTICASONE PROP HFA 44 MCG 10.6GM, a pharmaceutical product, to the Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,643.14, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 18, 2024, with a completion date of July 19, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type, and there is no set-aside designation....
This federal contract award is for the delivery of FLUTICASONE PROP HFA 110 MCG 12GM pharmaceutical product to the Defense Logistics Agency (DLA). The $8,793.62 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This federal contract award is for the delivery of FLUTICASONE PROP HFA 110 MCG 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,553.70 and is a firm fixed-price delivery order. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical,...
This federal contract award is for the delivery of 4,566,779,327 units of Fluticasone Propionate HFA 220 MCG 12GM, a pharmaceutical product. The contract, valued at $12,166.56, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, placed by the Defense Logistics Agency (DLA), a defense agency. This contract is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of Fluticasone Prop HFA 220 MCG 12GM pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, in the amount of $1,642.32. This is a firm fixed price delivery order contract with a completion date of June 14, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award is for the delivery of 4,564,977,955 units of Fluticasone Prop HFA 220 MCG 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, through a Delivery Order under the company's existing Indefinite Delivery Contract (IDC) with the DLA valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for...
This federal contract award is a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of FLUTICASONE PROP HFA 44 MCG 10.6GM. The contract has a firm fixed price of $2,534.75 and an ultimate completion date of June 11, 2025. The funding agency is the Defense Logistics Agency (DLA), a defense agency responsible for providing supplies and services to military forces. This contract is not set aside and was competitively awarded. Amerisourcebergen Drug...
This federal contract award is for the delivery of FLUTICASONE PROP HFA 110 MCG 12GM pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The $8,072.66 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider that specializes in supplying medical products to federal agencies. The contract has an ultimate completion date of December 19, 2024 and does not have a...
The federal contract award is for the delivery of fluticasone propionate HFA 110 mcg 12 gm inhalers to the Defense Logistics Agency (DLA). The $9,255.34 firm fixed price delivery order was awarded to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 and awarded solely to Amerisourcebergen Drug...
This federal contract award is for the delivery of fluticasone propionate HFA 44 mcg 10.6 gm to the Defense Logistics Agency (DLA). The $2,846.20 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a period of performance through November 4, 2024 and was not designated with a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...